Selected research
Industry Research
Addiction Treatment Industry Research Report 2026
Market perspective
The global Addiction Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Addiction Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Addiction Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Addiction Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Addiction Treatment include Purdue Pharma, Pfizer, GlaxoSmithKiline, Reckitt Benckiser, Orexo, Mallinckrodt, Cipla, Allergan and Alkermes. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Addiction Treatment market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Addiction Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Addiction Treatment Market by Company
Purdue Pharma
Pfizer
GlaxoSmithKiline
Reckitt Benckiser
Orexo
Mallinckrodt
Cipla
Allergan
Alkermes
Addiction Treatment Segment by Type
Tobacco/Nicotine Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Alcohol Addiction Treatment
Other Substance Addiction Treatment
Addiction Treatment Segment by Application
Residential Treatment Center
Inpatient Treatment Center
Outpatient Treatment Center
Addiction Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Addiction Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Addiction Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Addiction Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Addiction Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tobacco/Nicotine Addiction Treatment
- Tobacco/Nicotine Addiction Treatment
- Alcohol Addiction Treatment
- Other Substance Addiction Treatment
Applications
- Residential Treatment Center
- Inpatient Treatment Center
- Outpatient Treatment Center
Companies covered
- Purdue Pharma
- Pfizer
- GlaxoSmithKiline
- Reckitt Benckiser
- Orexo
- Mallinckrodt
- Cipla
- Allergan
- Alkermes
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Addiction Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Tobacco/Nicotine Addiction Treatment
- 2.2.3 Tobacco/Nicotine Addiction Treatment
- 2.2.4 Alcohol Addiction Treatment
- 2.2.5 Other Substance Addiction Treatment
- 2.3 Addiction Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Residential Treatment Center
- 2.3.3 Inpatient Treatment Center
- 2.3.4 Outpatient Treatment Center
- 2.4 Assumptions and Limitations
3 Addiction Treatment Breakdown Data by Type
- 3.1 Global Addiction Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Addiction Treatment Forecasted Market Size by Type (2027-2032)
4 Addiction Treatment Breakdown Data by Application
- 4.1 Global Addiction Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Addiction Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Addiction Treatment Market Perspective (2021-2032)
- 5.2 Global Addiction Treatment Growth Trends by Region
- 5.2.1 Global Addiction Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Addiction Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Addiction Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Addiction Treatment Market Dynamics
- 5.3.1 Addiction Treatment Industry Trends
- 5.3.2 Addiction Treatment Market Drivers
- 5.3.3 Addiction Treatment Market Challenges
- 5.3.4 Addiction Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Addiction Treatment Players by Revenue
- 6.1.1 Global Top Addiction Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Addiction Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Addiction Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Addiction Treatment Head Office and Area Served
- 6.4 Global Addiction Treatment Players, Product Type & Application
- 6.5 Global Addiction Treatment Manufacturers Established Date
- 6.6 Global Addiction Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Addiction Treatment Market Size (2021-2032)
- 7.2 North America Addiction Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Addiction Treatment Market Size by Country (2021-2026)
- 7.4 North America Addiction Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Addiction Treatment Market Size (2021-2032)
- 8.2 Europe Addiction Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Addiction Treatment Market Size by Country (2021-2026)
- 8.4 Europe Addiction Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Addiction Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Addiction Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Addiction Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Addiction Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Addiction Treatment Market Size (2021-2032)
- 10.2 South America Addiction Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Addiction Treatment Market Size by Country (2021-2026)
- 10.4 South America Addiction Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Addiction Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Addiction Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Addiction Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Addiction Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Purdue Pharma
- 12.1.1 Purdue Pharma Company Information
- 12.1.2 Purdue Pharma Business Overview
- 12.1.3 Purdue Pharma Revenue in Addiction Treatment Business (2021-2026)
- 12.1.4 Purdue Pharma Addiction Treatment Product Portfolio
- 12.1.5 Purdue Pharma Recent Developments
- 12.2 Pfizer
- 12.2.1 Pfizer Company Information
- 12.2.2 Pfizer Business Overview
- 12.2.3 Pfizer Revenue in Addiction Treatment Business (2021-2026)
- 12.2.4 Pfizer Addiction Treatment Product Portfolio
- 12.2.5 Pfizer Recent Developments
- 12.3 GlaxoSmithKiline
- 12.3.1 GlaxoSmithKiline Company Information
- 12.3.2 GlaxoSmithKiline Business Overview
- 12.3.3 GlaxoSmithKiline Revenue in Addiction Treatment Business (2021-2026)
- 12.3.4 GlaxoSmithKiline Addiction Treatment Product Portfolio
- 12.3.5 GlaxoSmithKiline Recent Developments
- 12.4 Reckitt Benckiser
- 12.4.1 Reckitt Benckiser Company Information
- 12.4.2 Reckitt Benckiser Business Overview
- 12.4.3 Reckitt Benckiser Revenue in Addiction Treatment Business (2021-2026)
- 12.4.4 Reckitt Benckiser Addiction Treatment Product Portfolio
- 12.4.5 Reckitt Benckiser Recent Developments
- 12.5 Orexo
- 12.5.1 Orexo Company Information
- 12.5.2 Orexo Business Overview
- 12.5.3 Orexo Revenue in Addiction Treatment Business (2021-2026)
- 12.5.4 Orexo Addiction Treatment Product Portfolio
- 12.5.5 Orexo Recent Developments
- 12.6 Mallinckrodt
- 12.6.1 Mallinckrodt Company Information
- 12.6.2 Mallinckrodt Business Overview
- 12.6.3 Mallinckrodt Revenue in Addiction Treatment Business (2021-2026)
- 12.6.4 Mallinckrodt Addiction Treatment Product Portfolio
- 12.6.5 Mallinckrodt Recent Developments
- 12.7 Cipla
- 12.7.1 Cipla Company Information
- 12.7.2 Cipla Business Overview
- 12.7.3 Cipla Revenue in Addiction Treatment Business (2021-2026)
- 12.7.4 Cipla Addiction Treatment Product Portfolio
- 12.7.5 Cipla Recent Developments
- 12.8 Allergan
- 12.8.1 Allergan Company Information
- 12.8.2 Allergan Business Overview
- 12.8.3 Allergan Revenue in Addiction Treatment Business (2021-2026)
- 12.8.4 Allergan Addiction Treatment Product Portfolio
- 12.8.5 Allergan Recent Developments
- 12.9 Alkermes
- 12.9.1 Alkermes Company Information
- 12.9.2 Alkermes Business Overview
- 12.9.3 Alkermes Revenue in Addiction Treatment Business (2021-2026)
- 12.9.4 Alkermes Addiction Treatment Product Portfolio
- 12.9.5 Alkermes Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst